National Bank of Canada’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

National Bank of Canada’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-200	Closed	-$5K	–	3205
2024 Q3	$5K	Buy	+200	New	+$7.39K	﹤0.01%	2214

Other funds holding SXTP

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SHF

Safe Harbor Fiduciary Pensacola, Florida $105M AUM

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Bank of Canada's SXTP Position: Q4 2024 in Review

National Bank of Canada sold out of 60 Degrees Pharmaceuticals (SXTP) in Q4 2024, closing a stake of 200 shares — an estimated $5K sold.

National Bank of Canada first reported a position in SXTP in Q3 2024 and held it in 1 quarter. The position peaked at $5K in Q3 2024. 9 funds tracked by Wall St. Rank hold SXTP as of Q4 2024.

National Bank of Canada reported no remaining 60 Degrees Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
National Bank of Canada sold 200 60 Degrees Pharmaceuticals shares in Q4 2024, an estimated $5K.
National Bank of Canada first reported a position in 60 Degrees Pharmaceuticals in Q3 2024 and held it in 1 quarter.
National Bank of Canada's 60 Degrees Pharmaceuticals position peaked at $5K in Q3 2024.
9 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.